Study Stopped
No Enrollment
Evaluating UTI Diagnosis in Nursing Homes
1 other identifier
observational
N/A
1 country
1
Brief Summary
This prospective, multicenter, comparative cohort observational study is to determine whether the use of Guidance® UTI Clinical Pathway, a standardized infrastructure for specimen collection and result delivery, compared with current traditional pathways for urine testing reduces the proportion of UTI patients with poor outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2021
CompletedFirst Posted
Study publicly available on registry
March 25, 2021
CompletedStudy Start
First participant enrolled
June 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 8, 2024
CompletedMay 28, 2025
November 1, 2024
3 years
March 22, 2021
May 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Examine prospective data to determine if the use of Guidance® UTI Clinical Pathway, compared to traditional clinical pathways, will reduce the proportion of patients with UTI-related adverse events.
Examine the proportion of patients with UTI-related adverse events requiring emergency hospital services over the course the study with a composite measure of the number of UTI related ED visits and/or subsequent hospitalizations and/or sepsis events.
12 Months
Secondary Outcomes (3)
Examine prospective data to determine if the use of Guidance® UTI Clinical Pathway, compared to traditional clinical pathways, will reduce overall inappropriate antibiotic use.
30 Days
Examine prospective data to determine if the use of Guidance® UTI Clinical Pathway is more effective than standard urine testing approaches in the clinical evaluation of UTI diagnosis and management .
12 Months
Examine prospective data to determine if the use of Guidance® UTI Clinical Pathway, compared to traditional clinical pathways, will reduce UTI antibiotic collateral effects.
30 Days
Study Arms (2)
Guidance Clinical Pathway
Facilities will be provided a standardized infrastructure and process for collecting and reporting of urine test results including unique lab requisitions that contain the option to order Guidance® UTI, Standard Urine Culture (SUC), and Urine Analysis (UA) along with a protocol for results notification to a central point person within the Nursing Home (NH) facility
Traditional Clinical Pathway
Facilities will employ their current standard clinical care practices for suspected UTI, including SUC, UA, and Guidance® UTI testing as per current reporting practices. Providers at these facilities will have the option to order any diagnostic test they deem appropriate.
Eligibility Criteria
Cohort of residents residing in the NH facility during 12 consecutive months.-
You may qualify if:
- Certified skilled nursing facilities (SNF) and nursing homes (NH)
- Nonprofit or for-profit freestanding facility certified by Medicare and Medicaid
- Currently utilizing an EMR system
- Minimum bed size of 100
You may not qualify if:
- Assisted Living Facilities and Residential Care Facilities
- Participation in another UTI trial during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pathnosticslead
Study Sites (1)
Pathnostics
Irvine, California, 92614, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dave Baunoch, PhD
Clinical Trials
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2021
First Posted
March 25, 2021
Study Start
June 7, 2021
Primary Completion
May 30, 2024
Study Completion
November 8, 2024
Last Updated
May 28, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share